Clinical Trial Update: A Study to Evaluate SSGJ-707 in Advanced Gynecologic Cancer Patients [Phase 2]

View source ↗

Summary

This entry notes a Phase 2 clinical trial evaluating SSGJ-707 in advanced or recurrent gynecologic cancers, including endometrial cancer and platinum-resistant …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Cancer
• Ovarian Cancer

Drugs mentioned

• SSGJ-707

Snippet

Sponsor: Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. | Conditions: Advanced/recurrent Endometrial Cancer and Platinum-resistant Ovarian Cancer | Phase 2 | Status: RECRUITING